Lv51
1600 积分 2023-02-24 加入
Charged particle therapy—optimization, challenges and future directions
1个月前
已完结
Particle arc therapy: Status and potential
1个月前
已完结
Autophagy-modulating biomembrane nanostructures: A robust anticancer weapon by modulating the inner and outer cancer environment
1个月前
已完结
Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial
1个月前
已完结
A Phase 1b Clinical Trial of Neoadjuvant Radio-immunotherapy for Esophageal Squamous Cell Cancer
1个月前
已完结
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
2个月前
已完结
Machine Learning-Based Radiomics for Predicting Outcomes in Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy
2个月前
已完结
Corynoxine triggers cell death via activating PP2A and regulating AKT-mTOR/GSK3β axes in NSCLC
5个月前
已完结
Effect of radiation fractionation on IDO1 via the NF-κB/COX2 axis in non-small cell lung cancer
6个月前
已完结
Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis
6个月前
已完结
皖公网安备34019202002308
